| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
A single, subcutaneous, 30-microg dose of either a combination of the Yersinia pestis proteins F1+V or a F1-V fusion protein adsorbed to the adjuvant aluminum hydroxide, protected Hsd:ND4 mice for one year against pneumonic plague. The recombinant F1+V vaccine provided significant protection as early as day 14 postimmunization. The current Plague Vaccine USP in a single 0.2-ml dose did not provide significant protection in this mouse model. Antibody titers to F1 and V peaked at approximately 5-12 weeks postimmunization and were still detectable one year later. These F1 and V subunit vaccines may offer effective long-term immunity with a reduced dosage schedule when compared with the presently licensed, formalin-killed, whole-cell vaccine.
This article has been cited by other articles:
|
|
 |
|
  T. E. Rocke, S. Smith, P. Marinari, J. Kreeger, J. T. Enama, and B. S. Powell VACCINATION WITH F1-V FUSION PROTEIN PROTECTS BLACK-FOOTED FERRETS (MUSTELA NIGRIPES) AGAINST PLAGUE UPON ORAL CHALLENGE WITH YERSINIA PESTIS J. Wildl. Dis., January 1, 2008; 44(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Bubeck and P. H. Dube Yersinia pestis CO92{Delta}yopH Is a Potent Live, Attenuated Plague Vaccine Clin. Vaccine Immunol., September 1, 2007; 14(9): 1235 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yang, B. J. Hinnebusch, T. Trunkle, C. M. Bosio, Z. Suo, M. Tighe, A. Harmsen, T. Becker, K. Crist, N. Walters, et al. Oral Vaccination with Salmonella Simultaneously Expressing Yersinia pestis F1 and V Antigens Protects against Bubonic and Pneumonic Plague J. Immunol., January 15, 2007; 178(2): 1059 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Musson, M. Morton, N. Walker, H. M. Harper, H. V. McNeill, E. D. Williamson, and J. H. Robinson Sequential Proteolytic Processing of the Capsular Caf1 Antigen of Yersinia pestis for Major Histocompatibility Complex Class II-restricted Presentation to T Lymphocytes J. Biol. Chem., September 8, 2006; 281(36): 26129 - 26135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Parent, L. B. Wilhelm, L. W. Kummer, F. M. Szaba, I. K. Mullarky, and S. T. Smiley Gamma Interferon, Tumor Necrosis Factor Alpha, and Nitric Oxide Synthase 2, Key Elements of Cellular Immunity, Perform Critical Protective Functions during Humoral Defense against Lethal Pulmonary Yersinia pestis Infection. Infect. Immun., June 1, 2006; 74(6): 3381 - 3386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Goure, A. Pastor, E. Faudry, J. Chabert, A. Dessen, and I. Attree The V Antigen of Pseudomonas aeruginosa Is Required for Assembly of the Functional PopB/PopD Translocation Pore in Host Cell Membranes Infect. Immun., August 1, 2004; 72(8): 4741 - 4750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Anisimov, L. E. Lindler, and G. B. Pier Intraspecific Diversity of Yersinia pestis Clin. Microbiol. Rev., April 1, 2004; 17(2): 434 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Flashner, E. Mamroud, A. Tidhar, R. Ber, M. Aftalion, D. Gur, S. Lazar, A. Zvi, T. Bino, N. Ariel, et al. Generation of Yersinia pestis Attenuated Strains by Signature-Tagged Mutagenesis in Search of Novel Vaccine Candidates Infect. Immun., February 1, 2004; 72(2): 908 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Grosfeld, S. Cohen, T. Bino, Y. Flashner, R. Ber, E. Mamroud, C. Kronman, A. Shafferman, and B. Velan Effective Protective Immunity to Yersinia pestis Infection Conferred by DNA Vaccine Coding for Derivatives of the F1 Capsular Antigen Infect. Immun., January 1, 2003; 71(1): 374 - 383. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
